1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsSmall Business Innovation Research (SBIR) & Small Business Technology Transfer (STTR) Programs is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) - NIH. This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Small Business Grants | NIAMS NIH Small Business Technology Transfer (STTR) program . NIH Small Business Innovation Research (SBIR) program . To learn more about the SBIR/STTR grants, visit: NIAMS SBIR/STTR website .
Small Business Technology Transfer (STTR) Program A set-aside program designed to support innovative research that has the potential for commercialization of the subject research conducted cooperatively by a small business concern and a research institution. Innovation and the potential for commercialization are two important aspects of the review criteria considered in the scientific and technical merit evaluation process.
At least 40% of the research project is to be conducted by the small business concern, and at least 30% of the work is to be conducted by the single, partnering research institution. A reasonable fee, not to exceed 7% of total costs (direct and indirect) for each Phase (I and II) of the project, can be requested solely to small business concerns receiving awards under the STTR program. Contact : Xibin Wang, Ph.
D. , [email protected] Applications Due : April 5, September 5, January 5 Additional Information : Office of Extramural Research: Small Business Innovation Research (SBIR) and Small Business Technology (STTR) Programs . Small Business Innovation Research (SBIR) Program A set-aside program designed to support innovative research that has the potential for commercialization of the subject research conducted by a small business concern.
Innovation and the potential for commercialization are two important aspects of the review criteria considered in the scientific and technical merit evaluation process. A reasonable fee, not to exceed 7% of total costs (direct and indirect) for each Phase (I and II) of the project, can be requested solely to small business concerns receiving awards under the SBIR program. Contact : Xibin Wang, Ph.
D.
, [email protected] Applications Due : April 5, September 5, January 5 Additional Information : Office of Extramural Research: Small Business Innovation Research (SBIR) and Small Business Technology (STTR) Programs Commercialization Readiness Program To support follow-on awards to small businesses for technology development, testing, evaluation, and commercialization assistance for SBIR or STTR Phase II technologies or for awards to small businesses to support the progress of research, research and development, and commercialization conducted under the SBIR or STTR programs to Phase III.
Small Business Innovation Research (SBIR) Cooperative Agreements—Phase II To support in-depth development of R&D ideas whose feasibility has been established in Phase I and that are likely to result in commercial products or services (also Fast Track). Contact : Xibin Wang, Ph. D.
(SBIR/STTR), [email protected]
According to the current listing, eligibility includes: U. S. -owned small businesses engaged in biomedical research and development. Eligibility is limited to U. S. -owned small businesses engaged in biomedical research and development. Confirm the full requirements in the official notice before applying.
The current listing shows varies by phase and program (Phase I up to $325,000; Phase II up to $2,000,000). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Small Business Innovation Research (SBIR) & Small Business Technology Transfer (STTR) Programs is funded by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) - NIH. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) - NIH. This program supports clinical trials that aim for meaningful improvements in the prevention, diagnosis, or treatment of rheumatic, musculoskeletal, or skin conditions or diseases. The goal is to reduce symptoms and improve outcomes and function in patients.
Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to accelerate translation and/or commercialization of musculoskeletal and skin tissue engineering and regenerative medicine research is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) - NIH. Solicits SBIR grant applications from small business concerns (SBCs) that propose to accelerate translation and/or commercialization of musculoskeletal and skin tissue engineering and regenerative medicine research. The focus is on pre-clinical studies with potential to immediately lead to phase I human clinical trials, or on development of pre-clinical animal models to assess safety and efficacy of potential commercial products.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article